Failure of response to combination therapy of adalimumab and infliximab in a recalcitrant patient of severe psoriasis and major thalassemia: A case report-Reference-Cited by-同舟云学术

Failure of response to combination therapy of adalimumab and infliximab in a recalcitrant patient of severe psoriasis and major thalassemia: A case report

Published:2020-02-03 Issue:3 Volume:8 Page:550-552
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Goldust Mohamad¹²³⁴^ORCID,Rahmatpour Rokni Ghasem⁵,Gupta Mrinal⁶,Lotti Torello⁷,Bathaei Marzieh¹

Affiliation:

1. Mazandaran University of Medical Sciences Sari Iran

2. University of Rome Guglielmo Marconi Rome Italy

3. Department of Dermatology University Medical Center Mainz Mainz Germany

4. Department of Dermatology University Hospital Basel Basel Switzerland

5. Department of Dermatology Mazandaran University of Medical Sciences Sari Iran

6. Treatwell Skin Centre Jammu India

7. Department of Dermatology University of Studies Guglielmo Marconi Rome Italy

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.2696

Reference9 articles.

1. Infliximab induction therapy for patients with severe plaque-type psoriasis: A randomized, double-blind, placebo-controlled trial

2. Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind study

3. Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials

4. Adalimumab in chronic plaque psoriasis: a clinical guide;Wu JJ;J Drug Dermatol,2017

5. Infliximab for the treatment of plaque psoriasis;Gall JS;Biologics,2008

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab induced exacerbation of psoriasis in patients with combined pemphigus: A case report;Medicine;2024-01-26

2. Review of Dual Biologics in Specialty Pharmacy Practice;Annals of Pharmacotherapy;2023-01-04

3. Interleukin 23p19 inhibitors in chronic plaque psoriasis with focus on mirikizumab: A narrative review;Dermatologic Therapy;2020-07